National Cancer Institute; Notice of Closed Meetings, 33769-33770 [2014-13674]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 113 / Thursday, June 12, 2014 / Notices
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: June 5, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2014–13675 Filed 6–11–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
rmajette on DSK7SPTVN1PROD with NOTICES
Name of Committee: Arthritis and
Musculoskeletal and Skin Diseases Initial
Review Group; Arthritis and Musculoskeletal
and Skin Diseases Clinical Trials Review
Committee.
Date: July 8–9, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Charles H. Washabaugh,
Ph.D., Scientific Review Officer, Scientific
Review Branch, NIAMS/NIH, 6701
Democracy Boulevard, Suite 800, Bethesda,
MD 20892, 301–594–4952 washabac@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Ancillary Studies to
PENUT.
Date: July 14, 2014.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Barbara A. Woynarowska,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 754, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
402–7172, woynarowskab@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: June 6, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–13680 Filed 6–11–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: June 6, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2014–13679 Filed 6–11–14; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the Board of
BILLING CODE 4140–01–P
VerDate Mar<15>2010
21:18 Jun 11, 2014
Jkt 232001
National Cancer Institute; Notice of
Closed Meetings
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
33769
Scientific Counselors for Basic Sciences,
National Cancer Institute and the Board
of Scientific Counselors for Clinical
Sciences and Epidemiology, National
Cancer Institute.
The meetings will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Cancer Institute, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors for Basic Sciences, National
Cancer Institute.
Date: July 15, 2014.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C-Wing, 6th
Floor, Conference Room 6, Bethesda, MD
20892.
Contact Person: Mehrdad M. Tondravi,
Ph.D., Executive Secretary, Institute Review
Office, Office of the Director, National Cancer
Institute, National Institutes of Health, 9609
Medical Center Drive, Room 2W464,
Rockville, MD 20850, 240–276–5664,
tondravim@mail.nih.gov.
Name of Committee: Board of Scientific
Counselors for Clinical Sciences and
Epidemiology, National Cancer Institute.
Date: July 14, 2014.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing, 6th
Floor, Conference Room 6, Bethesda, MD
20892.
Contact Person: Brian E. Wojcik, Ph.D.,
Executive Secretary, Institute Review Office,
Office of the Director, National Cancer
Institute, National Institutes of Health, 9609
Medical Center Drive, Room 3W414,
Rockville, MD 20850, 240–276–5665,
wojcikb@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
E:\FR\FM\12JNN1.SGM
12JNN1
33770
Federal Register / Vol. 79, No. 113 / Thursday, June 12, 2014 / Notices
Dated: June 5, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–13674 Filed 6–11–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
rmajette on DSK7SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–13–
080: Accelerating the Pace of Drug Abuse
Research Using Existing Data.
Date: June 24, 2014.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: George Vogler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3140,
MSC 7770, Bethesda, MD 20892, (301) 237–
2693, voglergp@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Skeletal Biology and Tissue
Engineering.
Date: July 8–9, 2014.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Yanming Bi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214,
MSC 7814, Bethesda, MD 20892, 301–451–
0996, ybi@csr.nih.gov.
VerDate Mar<15>2010
21:18 Jun 11, 2014
Jkt 232001
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Interventions for Health Behavior
over the Life Course.
Date: July 8, 2014.
Time: 11:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Mary Ann Guadagno,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170,
MSC 7770, Bethesda, MD 20892, (301) 451–
8011, guadagma@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Health and Behavior.
Date: July 8, 2014.
Time: 12:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Stacey C FitzSimmons,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114,
MSC 7808, Bethesda, MD 20892, 301–451–
9956, fitzsimmonss@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Comparative
Medicine Training.
Date: July 9, 2014.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Paul Sammak, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6185,
MSC 7892, Bethesda, MD 20892, 301–435–
0601, sammakpj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AREA:
Genes, Genomes and Genetics applications.
Date: July 9, 2014.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Michael M. Sveda, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2204,
MSC 7890, Bethesda, MD 20892, 301–435–
3565, svedam@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
PO 00000
Frm 00058
Fmt 4703
Sfmt 9990
Dated: June 6, 2014.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–13673 Filed 6–11–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Center for Substance Abuse
Treatment; Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Treatment
(CSAT) National Advisory Council will
meet June 19, 2014, 4:00–5:00 p.m. via
teleconference.
The meeting is open to the public and
will include discussions and evaluation
of grant applications reviewed by
SAMHSA’s Initial Review Groups. To
attend on-site, or request special
accommodations for persons with
disabilities, please register at SAMHSA
Committees’ Web site, https://nac.
samhsa.gov/Registration/meetings
Registration.aspx, or contact the
Council’s Designated Federal Officer,
Ms. Cynthia Graham, (see contact
information below). Substantive
program information, a summary of the
meeting, and a roster of Council
members may be obtained as soon as
possible after the meeting, by accessing
the SAMHSA Committee Web site at
https://beta.samhsa.gov/about-us/
advisory-councils/csat-nationaladvisory-council, or by contacting the
DFO.
Committee Name: SAMHSA’s Center for
Substance Abuse Treatment National
Advisory Council.
Date/Time/Type: June 19, 2014, 4:00–5:00
p.m. OPEN.
Place: SAMHSA Building, 1 Choke Cherry
Road, Great Falls Conference Room,
Rockville, Maryland 20857.
Contact: Cynthia Graham, M.S., Designated
Federal Official, SAMHSA CSAT National
Advisory Council, 1 Choke Cherry Road,
Room 5–1035, Rockville, Maryland 20857,
Telephone: (240) 276–1692, Fax: (240) 276–
1690, Email: cynthia.graham@
samhsa.hhs.gov.
Cathy J. Friedman,
Public Health Analyst, SAMHSA.
This notice is being published less than 15
days prior to the meeting due to the urgent
need to meet timing limitations imposed by
the review and funding cycle.
[FR Doc. 2014–13670 Filed 6–11–14; 8:45 am]
BILLING CODE 4162–20–P
E:\FR\FM\12JNN1.SGM
12JNN1
]]>Agencies
[Federal Register Volume 79, Number 113 (Thursday, June 12, 2014)]
[Notices]
[Pages 33769-33770]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-13674]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of meetings of the
Board of Scientific Counselors for Basic Sciences, National Cancer
Institute and the Board of Scientific Counselors for Clinical Sciences
and Epidemiology, National Cancer Institute.
The meetings will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Cancer Institute, including consideration of personnel qualifications
and performance, and the competence of individual investigators, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Board of Scientific Counselors for Basic
Sciences, National Cancer Institute.
Date: July 15, 2014.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 31, 31 Center
Drive, C-Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892.
Contact Person: Mehrdad M. Tondravi, Ph.D., Executive Secretary,
Institute Review Office, Office of the Director, National Cancer
Institute, National Institutes of Health, 9609 Medical Center Drive,
Room 2W464, Rockville, MD 20850, 240-276-5664,
tondravim@mail.nih.gov.
Name of Committee: Board of Scientific Counselors for Clinical
Sciences and Epidemiology, National Cancer Institute.
Date: July 14, 2014.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 31, 31 Center
Drive, C Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892.
Contact Person: Brian E. Wojcik, Ph.D., Executive Secretary,
Institute Review Office, Office of the Director, National Cancer
Institute, National Institutes of Health, 9609 Medical Center Drive,
Room 3W414, Rockville, MD 20850, 240-276-5665, wojcikb@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
[[Page 33770]]
Dated: June 5, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-13674 Filed 6-11-14; 8:45 am]
BILLING CODE 4140-01-P
